Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ipsen Shores Up Cash-Generating Primary Care Business With Sanofi CHC Buy

Feb 13 2017

• By Sukaina Virji

Related Content

Ipsen Pays $575m Upfront For Struggling Pancreatic Drug Onivyde

Jan 10 2017

From Onivyde To OTx: Ipsen Fortifies Oncology with Primary Care Dealmaking

Feb 01 2017

Additional Topics

Commercial Business Strategies Deals Companies BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.